Medicamen Organics Limited (NSE:MEDIORG)

Medicamen Organics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	13.03	41.3	5.53	5.28	4.37
Cash & Short-Term Investments	13.03	41.3	5.53	5.28	4.37
Cash Growth	-68.45%	646.89%	4.70%	20.76%	-51.48%
Receivables	186.28	258.52	167	107.68	62.45
Inventory	105.18	74.89	61.43	61.39	47.22
Prepaid Expenses	0.99	0.54	0.44	1.09	1.17
Other Current Assets	63.09	79.06	38.73	33.22	39.06
Total Current Assets	368.56	454.32	273.12	208.66	154.28
Property, Plant & Equipment	129.31	123.31	104.86	108.57	112.77
Long-Term Investments	0.49	0.25	0.25	0.21	0.03
Goodwill	-	0.01	-	-	-
Other Intangible Assets	5.33	0.14	0.1	0.12	0.14
Long-Term Deferred Tax Assets	0.99	-	-	-	-
Other Long-Term Assets	11.6	14.05	6.08	8.3	8.16
Total Assets	516.29	592.07	384.4	325.86	275.38

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	55.56	117.33	70.8	89.99	73.09
Accrued Expenses	11.27	8.87	8.05	6.23	4.68
Short-Term Debt	131.03	120.57	123.3	111.54	91.84
Current Portion of Long-Term Debt	1.45	1.39	1.65	3.15	4.21
Current Income Taxes Payable	1.67	13.59	9.04	3.69	0.77
Other Current Liabilities	16.52	9.82	3.36	4.4	0.83
Total Current Liabilities	217.5	271.56	216.19	218.99	175.42
Long-Term Debt	10.45	1.58	1.61	3.26	6.41
Pension & Post-Retirement Benefits	2.01	2.08	1.75	1.72	1.89
Long-Term Deferred Tax Liabilities	-	11.6	11.85	11.65	11.14
Other Long-Term Liabilities	0.47	0.45	0.4	0.44	0.41
Total Liabilities	230.42	287.27	231.81	236.06	195.27

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	121.66	117	86	60	60
Additional Paid-In Capital	120.89	95.54	21.14	9.14	9.14
Retained Earnings	44.73	81.25	45.45	20.66	10.96
Comprehensive Income & Other	-	7.5	-	-	-
Total Common Equity	287.27	301.29	152.59	89.8	80.11
Minority Interest	-1.41	3.51	-	-	-
Shareholders' Equity	285.87	304.81	152.59	89.8	80.11
Total Liabilities & Equity	516.29	592.07	384.4	325.86	275.38

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	142.93	123.53	126.57	117.95	102.46
Net Cash (Debt)	-129.9	-82.23	-121.04	-112.67	-98.08
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-11.02	-7.44	-16.00	-18.78	-16.35
Filing Date Shares Outstanding	12.17	11.7	8.6	6	6
Total Common Shares Outstanding	12.17	11.7	8.6	6	6
Working Capital	151.07	182.76	56.93	-10.33	-21.14
Book Value Per Share	23.61	25.75	17.74	14.97	13.35
Tangible Book Value	281.94	301.15	152.49	89.68	79.97
Tangible Book Value Per Share	23.17	25.74	17.73	14.95	13.33
Land	6.19	6.19	6.19	5.37	5.37
Buildings	57.1	54.56	54.56	47.96	47.84
Machinery	152.74	122.06	118.35	113.31	110.55
Construction In Progress	0.92	22.16	1.46	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error